论文信息 - Minimizing waste during preparation of blinatumomab infusions.

Minimizing waste during preparation of blinatumomab infusions.

Annual cancer drug expenditures exceed $100 billion globally.[1][1] The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 prohibits Medicare from negotiating drug prices.[2][2] Since the passing of this legislation, the average price for a newly approved cancer drug has

D. Bixby | Anthony J. Perissinotti | B. Marini | P. Burke | Andrew R Wechter

[1] H. Kantarjian,et al. Why are cancer drugs so expensive in the United States, and what are the solutions? , 2015, Mayo Clinic proceedings.

[2] R. Larson,et al. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study. , 2015, The Lancet. Oncology.

[3] H. Kantarjian,et al. Market spiral pricing of cancer drugs , 2013, Cancer.

[4] P. C. Morgan,et al. Overview of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 , 2004 .

[5] M J Ball,et al. Healthcare Informatics , 2009, Encyclopedia of Database Systems.